ES2437270B1 - Derivados de dihidroindeno, su preparación y su uso como medicamentos - Google Patents

Derivados de dihidroindeno, su preparación y su uso como medicamentos Download PDF

Info

Publication number
ES2437270B1
ES2437270B1 ES201231032A ES201231032A ES2437270B1 ES 2437270 B1 ES2437270 B1 ES 2437270B1 ES 201231032 A ES201231032 A ES 201231032A ES 201231032 A ES201231032 A ES 201231032A ES 2437270 B1 ES2437270 B1 ES 2437270B1
Authority
ES
Spain
Prior art keywords
medicines
preparation
dihydroindene
derivatives
dihydroindene derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201231032A
Other languages
English (en)
Other versions
ES2437270A1 (es
Inventor
María De Las Ermitas ALCALDE-PAÍS
María De Les Neus MESQUIDA-ESTÉVEZ
Laura PALOMA-ROMEU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Priority to ES201231032A priority Critical patent/ES2437270B1/es
Publication of ES2437270A1 publication Critical patent/ES2437270A1/es
Application granted granted Critical
Publication of ES2437270B1 publication Critical patent/ES2437270B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/84—Hydrazones having doubly-bound carbon atoms of hydrazone groups being part of rings other than six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Derivados de dihidroindeno, su preparación y su uso como medicamentos.#La presente invención se refiere a nuevos derivados de dihidroindeno que tienen una gran afinidad por receptores sigma, especialmente receptores sigma-1, así como al procedimiento para la preparación de las mismas, a composiciones que las comprenden, y a su uso como medicamentos.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11

Claims (1)

  1. imagen1
    imagen2
ES201231032A 2012-07-03 2012-07-03 Derivados de dihidroindeno, su preparación y su uso como medicamentos Expired - Fee Related ES2437270B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201231032A ES2437270B1 (es) 2012-07-03 2012-07-03 Derivados de dihidroindeno, su preparación y su uso como medicamentos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201231032A ES2437270B1 (es) 2012-07-03 2012-07-03 Derivados de dihidroindeno, su preparación y su uso como medicamentos

Publications (2)

Publication Number Publication Date
ES2437270A1 ES2437270A1 (es) 2014-01-09
ES2437270B1 true ES2437270B1 (es) 2014-10-14

Family

ID=49769817

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201231032A Expired - Fee Related ES2437270B1 (es) 2012-07-03 2012-07-03 Derivados de dihidroindeno, su preparación y su uso como medicamentos

Country Status (1)

Country Link
ES (1) ES2437270B1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1884515A1 (en) * 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments

Also Published As

Publication number Publication date
ES2437270A1 (es) 2014-01-09

Similar Documents

Publication Publication Date Title
CR20160033A (es) Inhibidores de autotaxina que comprenden un nucleo ciclico de anillo heteroaromático-bencil-amida
CU20140081A7 (es) Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
ECSP16059106A (es) Composiciones de liberación retardada de linaclotida
BR112016000489A2 (pt) composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos
CR20150114A (es) Composición farmacéutica recubierta que contiene regorafenib
BR112015022191A2 (pt) compostos heteroarila, seu uso e composição que os compreende
CU20140089A7 (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
DK3181122T3 (da) Farmaceutisk dasatinib-sammensætning
CR20140182A (es) Nuevos derivados de ciclohexilamina que tienen actividad como agonistas adrenérgicos b2 y como antagonistas muscarínicos m3
ECSP14013340A (es) Nuevos derivados de ciclohexilamina que tienen actividad como agonistas adrenérgicos ?2 y como antagonistas muscarínicos m3
BR112015031979A2 (pt) letermovir, formulação farmacêutica oral sólida, uso de uma formulação farmacêutica oral sólida, e processo para preparar letermovir.
BR112016011170A8 (pt) derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica
CO6920294A2 (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
DOP2013000307A (es) Antagonistas de trpv4
EA202190774A3 (ru) Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения
NI201200157A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
BR112014020992A2 (pt) Composto,uso de composto na fabricação de um medicamento e composição farmacêutica
SV2018005760A (es) Derivados de aminotiazol utiles como agentes antiviricos
BR112015025814A2 (pt) composição farmacêutica para uso inalatório, processo para a preparação de uma composição farmacêutica, composição sólida para uso como um diluente de pós para inalação e kit para a administração de um fármaco como pó para inalação
UY36329A (es) NUEVOS DERIVADOS BICÍCLICOS QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENÉRGICOS ß2 Y COMO ANTAGONISTAS MUSCARÍNICOS M3
UY35708A (es) Compuestos novedosos como antagonistas del receptor de ácido lisofosfatidico
CL2017000587A1 (es) Derivados de tetrahidroquinolina como inhibidores de bromodominio
BR112014026543A2 (pt) processo para a preparação de um material zeolítico, material zeolítico sintético, uso de um composto e uso de um material zeolítico
AR090975A1 (es) N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxihexil)amino)-2-oxo-n-fenil-1,2-dihidroquinolina-3-carboxamida

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2437270

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20141014

PC2A Transfer of patent

Owner name: ESTEVE PHARMACEUTICALS, S.A.

Effective date: 20181016

FD2A Announcement of lapse in spain

Effective date: 20231124